Osborne Clarke, Proskauer Rose LLP, and Matheson LLP have advised Grifols, S.A. and its group entities. Gómez-Acebo & Pombo and Milbank LLP have advised the financing...
Grifols Completes $5.3 Billion Cross-Border Refinancing to Extend Debt Maturities
Conversion of Biotest AG Into Partnership Limited by Shares
Osborne Clarke has advised Grifols S.A. Grifols S.A. completed the conversion of Biotest AG into a partnership limited by shares (Kommanditgesellschaft auf Aktien – KGaA), following...
Biotest Delisting from Frankfurt Stock Exchange Following Grifols’ Public Tender Offer
Ashurst has advised Biotest AG; Osborne Clarke has acted for Grifols S.A. Biotest AG has entered into a delisting agreement with GRIFOLS, S.A., as part of...
Grifols’ EUR1.1 Billion Acquisition Of Biotest
Osborne Clarke has advised Grifols on the deal. Grifols signed an agreement with the Hong Kong’s Tiancheng International Investment Ltd. to acquire 100% of the shares...
Grifols’ USD 1 Billion Strategic Investment From GIC
Osborne Clarke and Proskauer advised Grifols on the deal, while Dechert advised GIC. As part of the transaction, GIC will become a strategic investor in Grifols’...
Grifols’ $55.2 Million Acquisition of Seven Plasma Centres
Osborne Clarke advised Grifols on the deal. Grifols executed the acquisition of seven U.S. plasma donation centres from Kedrion for USD 55.2 million. The operation received regulatory...
Grifols’ $55.2 Million Acquisition of Seven Plasma Centres
Osborne Clarke advised Grifols on the deal. Grifols executed the acquisition of seven U.S. plasma donation centres from Kedrion for USD 55.2 million. The operation received regulatory...
Grifols’ $80 Million Acquisition of Remaining Stake in GigaGen
Osborne Clarke advised Grifols on the deal. Grifols executed the acquisition of remaining 56 per cent share capital in GigaGen Inc., for USD 80 million. GigaGen is a...
Grifols’ $370 Million Acquisition of 25 US-based Plasma Centres
Osborne Clarke advised Grifols on the deal while Greenberg Traurig, LLP represented Tiancheng Investment Management and its portfolio company Bio Products Laboratory. Grifols executed the $370...
Grifols’ $1.9 Billion Acquisition of Shanghai RAAS
Proskauer and JunHe advised Grifols in its alliance with Shanghai RAAS. Grandway Law Offices advised the seller. Pursuant to the transaction, Grifols S.A. (NASDAQ: GRFS) will exchange...